Elanco Announces Agreement as Exclusive Distributor of Aptimmune’s PRRS Killed Autogenous Vaccine in the United States
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with Aptimmune Biologics, Inc., as the exclusive distributor of their Porcine Reproductive and Respiratory Syndrome (PRRS) inactivated, or killed, vaccine based on Aptimmune’s Barricade® technology platform in the United States. An inactivated vaccine is one consisting of virus particles, bacteria or […]